CFDE Data Portal | Search NTAN1

	Label	Description
	NTAN1 Gene (Entity type)	ENSG00000157045 - N-terminal asparagine amidase
	NTAN1 associations Collection (Entity type)	Associations for NTAN1_associations
	NTAN1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 6 V 10 CRIZOTINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE116810 5 V 1 SELINEXOR HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 14 v 12 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE255432 7 V 3 IMEGLIMIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE158431 2 V 0 PIOGLITAZONE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE104022 1 V 0 TAMOXIFEN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS

NTAN1

ENSG00000157045 - N-terminal asparagine amidase

NTAN1 associations

Associations for NTAN1_associations

NTAN1 associations.tsv

A file from IDG as part of the Harmonizome project

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up

A Gene Set from LINCS

GSE239844 6 V 10 CRIZOTINIB HUMAN DN

A Gene Set from LINCS

GSE116810 5 V 1 SELINEXOR HUMAN UP

A Gene Set from LINCS

GSE111247 temozolomide LN-308 14 v 12 human dn

A Gene Set from LINCS

GSE255432 7 V 3 IMEGLIMIN MOUSE DN

A Gene Set from LINCS

GSE158431 2 V 0 PIOGLITAZONE MOUSE UP

A Gene Set from LINCS

GSE104022 1 V 0 TAMOXIFEN MOUSE DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.